Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-11-12 Sale | 2020-11-16 7:46 pm | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 20,000 | $10.19 | $203,824 | 35,844 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-01-26 Option Award | 2021-01-28 4:05 pm | N/A 2031-01-25 | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 50,000 | $0 | 50,000 (Direct) | View |
2020-11-12 Exercise | 2020-11-16 7:46 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 13,606 | $1.07 | 35,844 (Direct) | View |
2020-11-13 Exercise | 2020-11-16 7:46 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 3,755 | $1.14 | 35,844 (Direct) | View |
2020-11-13 Exercise | 2020-11-16 7:46 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 2,639 | $2.43 | 35,844 (Direct) | View |
2020-11-12 Exercise | 2020-11-16 7:46 pm | N/A 2023-01-22 | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 20,000 | $0 | 35,844 (Direct) | View |
2020-01-31 Option Award | 2020-02-04 6:05 pm | N/A 2030-01-30 | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 49,263 | $0 | 49,623 (Direct) | View |
Ownership | 2019-11-06 5:19 pm | N/A 2023-01-22 | Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer | 0 | $0 | 114,754 (Direct) | View |